240 related articles for article (PubMed ID: 35699942)
1. Context-dependent effects of IL-2 rewire immunity into distinct cellular circuits.
Whyte CE; Singh K; Burton OT; Aloulou M; Kouser L; Veiga RV; Dashwood A; Okkenhaug H; Benadda S; Moudra A; Bricard O; Lienart S; Bielefeld P; Roca CP; Naranjo-Galindo FJ; Lombard-Vadnais F; Junius S; Bending D; Ono MM; Hochepied T; Halim TYF; Schlenner S; Lesage S; Dooley J; Liston A
J Exp Med; 2022 Jul; 219(7):. PubMed ID: 35699942
[TBL] [Abstract][Full Text] [Related]
2. ALKS 4230: a novel engineered IL-2 fusion protein with an improved cellular selectivity profile for cancer immunotherapy.
Lopes JE; Fisher JL; Flick HL; Wang C; Sun L; Ernstoff MS; Alvarez JC; Losey HC
J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32317293
[TBL] [Abstract][Full Text] [Related]
3. Mouse cytomegalovirus infection overrules T regulatory cell suppression on natural killer cells.
Lindenberg M; Solmaz G; Puttur F; Sparwasser T
Virol J; 2014 Aug; 11():145. PubMed ID: 25108672
[TBL] [Abstract][Full Text] [Related]
4. Sustained IL-2R signaling of limited duration by high-dose mIL-2/mCD25 fusion protein amplifies tumor-reactive CD8
Hernandez R; Toomer KH; Põder J; Santos Savio A; Hsiung S; Malek TR
Cancer Immunol Immunother; 2021 Apr; 70(4):909-921. PubMed ID: 33037893
[TBL] [Abstract][Full Text] [Related]
5. Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosis.
Dinh TN; Kyaw TS; Kanellakis P; To K; Tipping P; Toh BH; Bobik A; Agrotis A
Circulation; 2012 Sep; 126(10):1256-66. PubMed ID: 22851544
[TBL] [Abstract][Full Text] [Related]
6. Regulatory T cells suppress natural killer cells during plasmid DNA vaccination in mice, blunting the CD8+ T cell immune response by the cytokine TGFbeta.
Frimpong-Boateng K; van Rooijen N; Geiben-Lynn R
PLoS One; 2010 Aug; 5(8):e12281. PubMed ID: 20808850
[TBL] [Abstract][Full Text] [Related]
7. IL-2-dependent adaptive control of NK cell homeostasis.
Gasteiger G; Hemmers S; Bos PD; Sun JC; Rudensky AY
J Exp Med; 2013 Jun; 210(6):1179-87. PubMed ID: 23650439
[TBL] [Abstract][Full Text] [Related]
8. The Cytotoxic Activity of Natural Killer Cells Is Suppressed by IL-10
Littwitz-Salomon E; Malyshkina A; Schimmer S; Dittmer U
Front Immunol; 2018; 9():1947. PubMed ID: 30210499
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of IL-2 and IL-21 on expansion of the CD4+ CD25+ Foxp3+ T regulatory cells with redundant roles in natural killer cell mediated antibody dependent cellular cytotoxicity in chronic lymphocytic leukemia.
Gowda A; Ramanunni A; Cheney C; Rozewski D; Kindsvogel W; Lehman A; Jarjoura D; Caligiuri M; Byrd JC; Muthusamy N
MAbs; 2010; 2(1):35-41. PubMed ID: 20081380
[TBL] [Abstract][Full Text] [Related]
10. Innate inflammation drives NK cell activation to impair Treg activity.
Dean JW; Peters LD; Fuhrman CA; Seay HR; Posgai AL; Stimpson SE; Brusko MA; Perry DJ; Yeh WI; Newby BN; Haller MJ; Muir AB; Atkinson MA; Mathews CE; Brusko TM
J Autoimmun; 2020 Mar; 108():102417. PubMed ID: 32035746
[TBL] [Abstract][Full Text] [Related]
11. The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression.
Ghiringhelli F; Ménard C; Martin F; Zitvogel L
Immunol Rev; 2006 Dec; 214():229-38. PubMed ID: 17100888
[TBL] [Abstract][Full Text] [Related]
12. Targeting of TLRs inhibits CD4+ regulatory T cell function and activates lymphocytes in human peripheral blood mononuclear cells.
Voo KS; Bover L; Harline ML; Weng J; Sugimoto N; Liu YJ
J Immunol; 2014 Jul; 193(2):627-34. PubMed ID: 24928999
[TBL] [Abstract][Full Text] [Related]
13. IL2 Variant Circumvents ICOS+ Regulatory T-cell Expansion and Promotes NK Cell Activation.
Sim GC; Liu C; Wang E; Liu H; Creasy C; Dai Z; Overwijk WW; Roszik J; Marincola F; Hwu P; Grimm E; Radvanyi L
Cancer Immunol Res; 2016 Nov; 4(11):983-994. PubMed ID: 27697858
[TBL] [Abstract][Full Text] [Related]
14. CD8 T cells in innate immune responses: using STAT4-dependent but antigen-independent pathways to gamma interferon during viral infection.
Suarez-Ramirez JE; Tarrio ML; Kim K; Demers DA; Biron CA
mBio; 2014 Oct; 5(5):e01978-14. PubMed ID: 25336459
[TBL] [Abstract][Full Text] [Related]
15. Impaired NK cells' activity and increased numbers of CD4 + CD25+ regulatory T cells in multidrug-resistant Mycobacterium tuberculosis patients.
Fan R; Xiang Y; Yang L; Liu Y; Chen P; Wang L; Feng W; Yin K; Fu M; Xu Y; Wu J
Tuberculosis (Edinb); 2016 May; 98():13-20. PubMed ID: 27156613
[TBL] [Abstract][Full Text] [Related]
16. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.
Bergamaschi C; Pandit H; Nagy BA; Stellas D; Jensen SM; Bear J; Cam M; Valentin A; Fox BA; Felber BK; Pavlakis GN
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461349
[TBL] [Abstract][Full Text] [Related]
17. Modification of anti-tumor immunity by tolerogenic dendritic cells.
Chen L; Hasni MS; Jondal M; Yakimchuk K
Autoimmunity; 2017 Sep; 50(6):370-376. PubMed ID: 28675711
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of denileukin diftitox IL-2 immunotoxin on NK and regulatory T cells in nonhuman primates.
Yamada Y; Aoyama A; Tocco G; Boskovic S; Nadazdin O; Alessandrini A; Madsen JC; Cosimi AB; Benichou G; Kawai T
J Immunol; 2012 Jun; 188(12):6063-70. PubMed ID: 22586034
[TBL] [Abstract][Full Text] [Related]
19. Regulatory T cells control NK cells in an insulitic lesion by depriving them of IL-2.
Sitrin J; Ring A; Garcia KC; Benoist C; Mathis D
J Exp Med; 2013 Jun; 210(6):1153-65. PubMed ID: 23650440
[TBL] [Abstract][Full Text] [Related]
20. Enhanced suppression of polyclonal CD8
Mu C; Zhang X; Wang L; Xu A; Ahmed KA; Pang X; Chibbar R; Freywald A; Huang J; Zhu Y; Xiang J
J Leukoc Biol; 2017 May; 101(5):1221-1231. PubMed ID: 28096300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
